BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10074455)

  • 21. Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1.
    Ge R; Liu L; Dai W; Zhang W; Yang Y; Wang H; Shi Q; Guo S; Yi X; Wang G; Gao T; Luan Q; Li C
    J Invest Dermatol; 2016 Jun; 136(6):1219-1228. PubMed ID: 26880244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.
    Tsodikov OV; Ivanov D; Orelli B; Staresincic L; Shoshani I; Oberman R; Schärer OD; Wagner G; Ellenberger T
    EMBO J; 2007 Nov; 26(22):4768-76. PubMed ID: 17948053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways.
    Masters JR; Thomas R; Hall AG; Hogarth L; Matheson EC; Cattan AR; Lohrer H
    Eur J Cancer; 1996 Jun; 32A(7):1248-53. PubMed ID: 8758261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Bcl-x(L) protein in nucleotide excision repair-facilitated cell protection against cisplatin-induced apoptosis.
    Lomonaco SL; Xu XS; Wang G
    DNA Cell Biol; 2009 Jun; 28(6):285-94. PubMed ID: 19317621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
    Fan W; Zhang HL; Wu XM
    Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of damage-specific DNA binding of XPA by interaction with the ERCC1 DNA repair protein.
    Nagai A; Saijo M; Kuraoka I; Matsuda T; Kodo N; Nakatsu Y; Mimaki T; Mino M; Biggerstaff M; Wood RD
    Biochem Biophys Res Commun; 1995 Jun; 211(3):960-6. PubMed ID: 7598728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific association between the human DNA repair proteins XPA and ERCC1.
    Li L; Elledge SJ; Peterson CA; Bales ES; Legerski RJ
    Proc Natl Acad Sci U S A; 1994 May; 91(11):5012-6. PubMed ID: 8197174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin.
    Goldberg Z; Evans J; Birrell G; Brown JM
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):175-82. PubMed ID: 11163512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.
    Jordheim LP; Cros-Perrial E; Matera EL; Bouledrak K; Dumontet C
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):817-24. PubMed ID: 25115435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression and purification of human XPA using a baculovirus expression system.
    Hermanson IL; Turchi JJ
    Protein Expr Purif; 2000 Jun; 19(1):1-11. PubMed ID: 10833384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of a ternary complex by human XPA, ERCC1, and ERCC4(XPF) excision repair proteins.
    Park CH; Sancar A
    Proc Natl Acad Sci U S A; 1994 May; 91(11):5017-21. PubMed ID: 8197175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells.
    Köberle B; Roginskaya V; Wood RD
    DNA Repair (Amst); 2006 May; 5(5):641-8. PubMed ID: 16413230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH.
    Saijo M; Matsuda T; Kuraoka I; Tanaka K
    Biochem Biophys Res Commun; 2004 Sep; 321(4):815-22. PubMed ID: 15358100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
    Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
    Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconstitution of damage DNA excision reaction from SV40 minichromosomes with purified nucleotide excision repair proteins.
    Araki M; Masutani C; Maekawa T; Watanabe Y; Yamada A; Kusumoto R; Sakai D; Sugasawa K; Ohkuma Y; Hanaoka F
    Mutat Res; 2000 Mar; 459(2):147-60. PubMed ID: 10725665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro.
    Saijo M; Kuraoka I; Masutani C; Hanaoka F; Tanaka K
    Nucleic Acids Res; 1996 Dec; 24(23):4719-24. PubMed ID: 8972858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA repair gets physical: mapping an XPA-binding site on ERCC1.
    Croteau DL; Peng Y; Van Houten B
    DNA Repair (Amst); 2008 May; 7(5):819-26. PubMed ID: 18343204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
    Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
    Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair.
    Li L; Peterson CA; Lu X; Legerski RJ
    Mol Cell Biol; 1995 Apr; 15(4):1993-8. PubMed ID: 7891694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong functional interactions of TFIIH with XPC and XPG in human DNA nucleotide excision repair, without a preassembled repairosome.
    Araújo SJ; Nigg EA; Wood RD
    Mol Cell Biol; 2001 Apr; 21(7):2281-91. PubMed ID: 11259578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.